Stock listing
BOATS:ESLA Estrella Immunopharma, Inc. Stock
US listing (BOATS) of Estrella Immunopharma, Inc. · home listing NASDAQ:ESLA
Follow Estrella Immunopharma, Inc. into a list and get an email when it puts out news.
Home listing price · NASDAQ:ESLA
$0.426 USD -0.213 (-33.3%)
Close on Nov 2, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:ESLA
- Day range
- $0.425 – $0.639 USDNov 2, 2026
- Volume
- 616,974 sharesNov 2, 2026
- Market cap
- $18.54M USDAt the close on Nov 2, 2026 · price × 43.50M shares outstanding
- 52-week range
- $0.240 – $3.150 USDLowest and highest trades, Nov 3, 2025 – Nov 2, 2026
- Traded on an average day
- $958,181 USDMedian day 44,300 shares · last 3 months, Aug 3, 2026 – Nov 2, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:ESLA · Home | $0.426 USD | -0.213 (-33.3%) | 616,974 | $0.639 | $0.639 | $0.425 | $0.639 | Close on Nov 2, 2026 |
Daily closes
Last 3 months, Aug 3, 2026 – Nov 2, 2026 · NASDAQ:ESLA · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $0.426 | -0.213 | -33.3% | $0.639 | $0.639 | $0.425 | 616,974 | |
| $0.639 | -0.089 | -12.3% | $0.720 | $0.787 | $0.634 | 165,562 | |
| $0.729 | -0.093 | -11.3% | $0.812 | $0.825 | $0.701 | 270,200 | |
| $0.822 | -0.111 | -11.9% | $0.918 | $0.990 | $0.751 | 495,551 | |
| $0.932 | +0.014 | +1.5% | $0.880 | $0.950 | $0.846 | 587,604 | |
| $0.919 | -0.066 | -6.7% | $1.030 | $1.150 | $0.880 | 2,528,457 | |
| $0.985 | +0.258 | +35.5% | $0.764 | $0.999 | $0.741 | 3,671,500 | |
| $0.727 | +0.177 | +32.2% | $0.562 | $0.759 | $0.555 | 6,851,000 | |
| $0.550 | +0.150 | +37.5% | $0.419 | $0.591 | $0.388 | 7,019,400 | |
| $0.400 | +0.020 | +5.3% | $0.349 | $0.419 | $0.334 | 193,900 | |
| $0.380 | -0.050 | -11.6% | $0.369 | $0.424 | $0.240 | 1,695,900 | |
| $0.430 | -0.105 | -19.6% | $0.495 | $0.510 | $0.421 | 4,239,600 | |
| $0.535 | +0.217 | +68.2% | $0.310 | $0.850 | $0.302 | 63,107,500 | |
| $0.318 | +0.004 | +1.3% | $0.310 | $0.330 | $0.300 | 198,900 | |
| $0.314 | -0.015 | -4.6% | $0.330 | $0.342 | $0.295 | 319,000 | |
| $0.329 | -0.081 | -19.8% | $0.325 | $0.363 | $0.320 | 900,000 | |
| $0.410 | -0.008 | -1.9% | $0.352 | $0.443 | $0.308 | 19,847,400 | |
| $0.418 | -0.001 | -0.2% | $0.410 | $0.426 | $0.361 | 71,100 | |
| $0.419 | -0.010 | -2.3% | $0.412 | $0.443 | $0.412 | 48,900 | |
| $0.429 | -0.011 | -2.5% | $0.442 | $0.461 | $0.411 | 68,700 | |
| $0.440 | -0.028 | -6.0% | $0.460 | $0.460 | $0.440 | 31,100 | |
| $0.468 | -0.007 | -1.5% | $0.461 | $0.506 | $0.460 | 14,500 | |
| $0.475 | +0.008 | +1.7% | $0.460 | $0.480 | $0.460 | 14,400 | |
| $0.467 | +0.007 | +1.5% | $0.499 | $0.499 | $0.463 | 18,400 | |
| $0.460 | +0.029 | +6.7% | $0.470 | $0.490 | $0.440 | 26,100 | |
| $0.431 | -0.050 | -10.4% | $0.467 | $0.500 | $0.431 | 36,000 | |
| $0.481 | +0.010 | +2.1% | $0.471 | $0.500 | $0.467 | 27,800 | |
| $0.471 | -0.001 | -0.2% | $0.470 | $0.500 | $0.468 | 9,200 | |
| $0.472 | -0.013 | -2.7% | $0.475 | $0.500 | $0.461 | 32,300 | |
| $0.485 | -0.017 | -3.4% | $0.550 | $0.560 | $0.480 | 62,600 | |
| $0.502 | -0.027 | -5.1% | $0.531 | $0.580 | $0.500 | 52,000 | |
| $0.529 | +0.003 | +0.6% | $0.569 | $0.579 | $0.509 | 56,900 | |
| $0.526 | -0.114 | -17.8% | $0.650 | $0.650 | $0.510 | 149,900 | |
| $0.640 | +0.029 | +4.7% | $0.650 | $0.650 | $0.586 | 45,200 | |
| $0.611 | -0.025 | -3.9% | $0.680 | $0.680 | $0.594 | 48,100 | |
| $0.636 | -0.024 | -3.6% | $0.730 | $0.730 | $0.623 | 27,400 | |
| $0.660 | -0.013 | -1.9% | $0.696 | $0.720 | $0.660 | 25,900 | |
| $0.673 | +0.035 | +5.5% | $0.620 | $0.740 | $0.620 | 82,000 | |
| $0.638 | -0.002 | -0.3% | $0.610 | $0.685 | $0.610 | 28,600 | |
| $0.640 | -0.006 | -0.9% | $0.622 | $0.720 | $0.620 | 53,300 | |
| $0.646 | +0.005 | +0.8% | $0.725 | $0.738 | $0.585 | 69,400 | |
| $0.641 | -0.049 | -7.1% | $0.719 | $0.744 | $0.640 | 17,300 | |
| $0.690 | -0.002 | -0.3% | $0.703 | $0.725 | $0.690 | 17,400 | |
| $0.692 | -0.033 | -4.6% | $0.720 | $0.725 | $0.692 | 4,900 | |
| $0.725 | +0.020 | +2.8% | $0.680 | $0.730 | $0.660 | 13,100 | |
| $0.705 | -0.017 | -2.4% | $0.755 | $0.755 | $0.625 | 44,300 | |
| $0.722 | -0.008 | -1.1% | $0.740 | $0.750 | $0.707 | 41,800 | |
| $0.730 | -0.003 | -0.4% | $0.750 | $0.750 | $0.725 | 11,900 | |
| $0.733 | -0.002 | -0.3% | $0.759 | $0.770 | $0.720 | 38,300 | |
| $0.735 | 0.000 | 0.0% | $0.757 | $0.764 | $0.720 | 20,300 | |
| $0.735 | -0.010 | -1.3% | $0.761 | $0.761 | $0.721 | 8,200 | |
| $0.745 | +0.008 | +1.1% | $0.770 | $0.770 | $0.720 | 29,700 | |
| $0.737 | +0.005 | +0.7% | $0.720 | $0.801 | $0.720 | 53,400 | |
| $0.732 | -0.028 | -3.7% | $0.770 | $0.814 | $0.731 | 30,000 | |
| $0.760 | +0.037 | +5.1% | $0.735 | $0.850 | $0.720 | 96,800 | |
| $0.723 | -0.002 | -0.3% | $0.735 | $0.740 | $0.720 | 9,000 | |
| $0.725 | -0.015 | -2.0% | $0.720 | $0.740 | $0.720 | 16,200 | |
| $0.740 | +0.035 | +4.9% | $0.739 | $0.745 | $0.720 | 8,600 | |
| $0.705 | -0.017 | -2.3% | $0.721 | $0.744 | $0.690 | 13,307 | |
| $0.722 | -0.001 | -0.1% | $0.720 | $0.818 | $0.715 | 25,309 | |
| $0.723 | -0.023 | -3.1% | $0.710 | $0.745 | $0.710 | 5,600 | |
| $0.746 | -0.001 | -0.1% | $0.769 | $0.775 | $0.710 | 13,900 | |
| $0.747 | +0.043 | +6.1% | $0.795 | $0.800 | $0.715 | 99,500 | |
| $0.704 | +0.004 | +0.6% | $0.700 | $0.750 | $0.700 | 24,100 | |
| $0.700 | -0.014 | -2.0% | $0.737 | $0.747 | $0.678 | 26,900 |
- Ticker
- BOATS:ESLA
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- BOATS
- Currency
- USD
What changed lately
Latest news release · Oct 26, 2026
Estrella Immunopharma Appoints Cynthia Pussinen as Chief Executive Officer and Chairperson of the Board of Directors
Latest deck · March 2026
Investor Presentation (March 2026)
Investor deck · 27 slides
Latest news
Estrella Immunopharma Appoints Cynthia Pussinen as Chief Executive Officer and Chairperson of the Board of Directors
Oct 26, 2026
Closed $0.919 (-6.7%) on Oct 26, 2026
Estrella Immunopharma Treats First Patient with Two EB103 Infusions in STARLIGHT-1 Dose-Expansion Phase
Oct 15, 2026
Closed $0.43 (-19.6%) on Oct 16, 2026
Estrella Immunopharma Activates Intermountain Health LDS Hospital as Fifth Clinical Site for Phase I/II STARLIGHT-1 Trial in B-cell Non-Hodgkin’s Lymphoma
Oct 14, 2026
Closed $0.535 (+68.2%) on Oct 15, 2026
Estrella Immunopharma Announces First Patient Dosed in Dose-Expansion Phase of STARLIGHT-1 Trial and Reports Durable Response Rate in Advanced B-Cell Non-Hodgkin’s Lymphoma
Jul 24, 2026
Closed $0.78 (+2.1%) on Jul 24, 2026
Estrella Immunopharma to Participate in the D. Boral Capital Global Conference
May 5, 2026
Closed $1.41 (-8.0%) on May 5, 2026
Estrella Immunopharma, Inc. (NASDAQ: ESLA) Receives Initiating Coverage with a Valuation of $12.00/Share from Zacks Small-Cap Research
Mar 23, 2026
Closed $1.02 (-1.9%) on Mar 23, 2026
Estrella Immunopharma Presents Promising Updated Data on EB103 in Oral Presentation at the 2026 Tandem Meetings of ASTCT® & CIBMTR®
Feb 9, 2026
Closed $1.43 (-1.7%) on Feb 9, 2026
Estrella Immunopharma Announces Late-Breaking Oral Presentation of Phase 1 STARLIGHT-1 Data for EB103 at the 2026 Tandem Meetings of ASTCT® & CIBMTR®
Feb 3, 2026
Closed $1.17 (+7.3%) on Feb 3, 2026
Estrella Immunopharma Announces Closing of $8.0 Million Registered Direct Offering and Concurrent Private Placement
Jan 6, 2026
Closed $1.37 (+3.0%) on Jan 6, 2026
Decks
Investor Presentation (March 2026)
Investor deck · 27 slides · March 2026
Investor Presentation (April 2024)
Investor deck · 29 slides · Apr 10, 2024
Estrella Immunopharma, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 14 in the last 12 months · 21 in all · newest Oct 26, 2026 · oldest 2024
- Decks
- 2 decks · latest March 2026
Where Estrella Immunopharma, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:ESLA · Home listing | NASDAQ | United States | USD |
| BOATS:ESLA · This page | BOATS | United States | USD |
Log in to ask 6ix AI your own questions about Estrella Immunopharma, Inc.